Investor Presentaiton

Revenue $70.6m ($47.7m PCP) +48% Organic Revenue Growth on PCP; 31.4% 3-year CAGR Revenue Growth YoY by type 80,000 70,000 60,000 50,000 $'000 40,000 whispir 30,000 20,000 10,000 FY21 Platform and software revenue Transactional revenue Revenue Composition FY22 Financial Results - Investor Presentation FY22 FY21 Transactional revenue 77% 68% Platform revenue +68.2% Growth YoY 21% 29% Services and support 2% 3% FY22 +4.8% Growth YoY Professional services and configuration revenue Transactional revenue non-repeatable* Transactional revenue comprised 77% of total revenue, (68% PCP) due to the Australian state health departments vaccine roll out programs in response to Covid-19. 08 80

View entire presentation